Simple prognostic score for metastatic castration‐resistant prostate cancer with incorporation of neutrophil‐to‐lymphocyte ratio

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|21|3346-3352

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.21, 2014-11, pp. : 3346-3352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High neutrophil‐to‐lymphocyte ratio predicts poor clinical outcome in patients with castration‐resistant prostate cancer treated with docetaxel chemotherapy

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 9, 2015-09 ,pp. : 827-833

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment to High neutrophil‐to‐lymphocyte ratio predicts poor clinical outcome in patients with castration‐resistant prostate cancer treated with docetaxel chemotherapy

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 9, 2015-09 ,pp. : 834-834

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer‐related inflammation: An emerging prognostic domain in metastatic castration‐resistant prostate carcinoma

By  

CANCER, Vol. 120, Iss. 21, 2014-11 ,pp. : 3272-3274

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic role of neutrophil‐to‐lymphocyte ratio in head and neck cancer: A meta‐analysis

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 40, Iss. 3, 2018-03 ,pp. : 647-655

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is prostate cancer changing?: Evolving patterns of metastatic castration‐resistant prostate cancer

By  

CANCER, Vol. 120, Iss. 6, 2014-03 ,pp. : 833-839

John Wiley & Sons Inc

Access to resources Recommend Favorite